Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Raw Materials (2019 - 2024)

Historic Raw Materials for CureVac (CVAC) over the last 6 years, with Q2 2024 value amounting to -$36700.3.

  • CureVac's Raw Materials fell 16685.11% to -$36700.3 in Q2 2024 from the same period last year, while for Jun 2024 it was -$36700.3, marking a year-over-year decrease of 16685.11%. This contributed to the annual value of $64.2 million for FY2021, which is 29074.04% up from last year.
  • According to the latest figures from Q2 2024, CureVac's Raw Materials is -$36700.3, which was down 16685.11% from -$6041.3 recorded in Q1 2024.
  • Over the past 5 years, CureVac's Raw Materials peaked at $64.2 million during Q4 2021, and registered a low of -$36700.3 during Q2 2024.
  • In the last 5 years, CureVac's Raw Materials had a median value of -$5453.9 in 2024 and averaged $10.1 million.
  • In the last 5 years, CureVac's Raw Materials soared by 29074.04% in 2021 and then crashed by 61252.01% in 2022.
  • CureVac's Raw Materials (Quarter) stood at $16.4 million in 2020, then surged by 290.74% to $64.2 million in 2021, then plummeted by 100.04% to -$25620.7 in 2022, then soared by 46.32% to -$13753.1 in 2023, then tumbled by 166.85% to -$36700.3 in 2024.
  • Its Raw Materials was -$36700.3 in Q2 2024, compared to -$6041.3 in Q1 2024 and -$13753.1 in Q2 2023.